APR Applied Pharma Research s.a. (“APR”) and Labtec GmbH (“Labtec”) announce the European Approval of Ondansetron RapidFilm™

23 March 2010

Oncology: Palonosetron approved in Japan, second pharmaceutical market worldwide

20 January 2010